Clinical Trials in Baltimore

Showing 18001-18020 of 23,476 trials

A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease

NCT01274507

The purpose of this study is to characterize the clinical, physiologic, and molecular profiles of healthy participants, participants with mild, moderate, and severe asthma; and participants with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

AsthmaPulmonary Disease, Chronic Obstructive

Janssen Research & Development, LLC328 participantsStarted Jul 2010

Birmingham, Alabama, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +18 more locations

COMPLETEDPhase 3< 1 mile

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

NCT01444430

The purpose of the study is to evaluate the safety of Symbicort compared to inhaled corticosteroid alone during 6 months in adult and adolescent patients with asthma

Asthma

AstraZeneca12,460 participantsStarted Dec 2011

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Anchorage, Alaska, United States +337 more locations

A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Find Trials by Condition in Baltimore

Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)

Mental Health Services for Foster and Adopted Children

Mental Health Services for Toddlers in Foster Care

Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort

A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment

A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia

Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB

Assessment of the Clinical Performance of the ARROW-FLU System

Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)

A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)